back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-08-25 18:05 Tx date 2025-08-22 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+40,000 vol |
40,000 | |
| Filed 2025-08-25 18:04 Tx date 2019-05-23 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-25 18:04 Tx date 2025-08-22 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-40,000 vol |
40,000 | |
| Filed 2025-08-25 18:04 Tx date 2025-01-31 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+80,000 vol |
80,000 | |
| Filed 2025-08-25 17:59 Tx date 2019-05-23 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 19:08 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2023-04-10 13:46 Tx date 2023-04-03 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2023-04-10 13:44 Tx date 2019-05-23 |
$BNXT
BioNxt Solutions Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-03 16:36 Tx date 2021-04-30 |
$
Defence Therapeutics Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2021-05-03 16:36 Tx date 2021-04-30 |
$
Defence Therapeutics Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-06-04 15:40 Tx date 2019-05-23 |
$
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Loebenberg, Raimar
4 - Director of Issuer
Holder: JRCPharmaceuticals Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,000 |